📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Genoway

1.1 - Company Overview

Genoway Logo

Genoway

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of genetically modified mouse, rat, and cell line models for preclinical research in biopharma and academia. Delivers humanized, knockin, and conditional knockout models and inducible, spatiotemporal gene control using RMCE, FLEx, SSR, TET system, and homologous recombination, enabling gene insertions, deletions, inversions and to predict the success of new therapies.

Products and services

  • Preclinical Mouse, Rat & Cell Lines: genOway architects research-grade genetically modified mouse, rat, and cell lines for preclinical research, enabling physiologically relevant testing to predict the success of new therapies
  • Homologous Recombination: genOway deploys a precision-engineered gene targeting platform to create humanized, knockin, and conditional knockout models explicitly tailored for human disease studies
  • RMCE (Recombinase-Mediated Cassette Exchange): This modular recombination system swaps large genomic regions to generate humanized models and multiple mutants from a single parental ES cell clone

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Genoway

Seer Logo

Seer

HQ: United States Website
  • Description: Provider of proteomics tools and solutions, including the Proteograph Product Suite (integrated workflow with instruments, consumables, and software for deep, large-scale proteome analysis); Proteograph Analysis Suite for LC-MS data processing, analysis, and visualization; SP100 Automation Instrument; Proteograph Assay Kit; and Seer Technology Access Center services for proteomics research support.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Seer company profile →
NeoPhore Logo

NeoPhore

HQ: United Kingdom Website
  • Description: Provider of novel small molecule cancer therapies that stimulate the immune system by targeting DNA mismatch repair to induce neoantigen expression and increase immunogenicity in solid tumors, including PMS2 and MLH1 modulators that convert immune-cold tumors to hot and enhance sensitivity to immune checkpoint inhibitors, plus continuous neoantigen creation and research and development on next-generation targets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NeoPhore company profile →
Medicinal Genomics Logo

Medicinal Genomics

HQ: The Netherlands Website
  • Description: Provider of genomics-driven testing and breeding solutions for medical cannabis and hemp, including the PathoSEEK qPCR-based microbial safety testing platform and detection assays for flower, extracts, and infused products; SenSATIVAx DNA purification kits; FemINDICAtor qPCR plant sex testing; and genomic services to identify markers for desirable traits and accelerate breeding programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medicinal Genomics company profile →
Azitra Logo

Azitra

HQ: United States Website
  • Description: Provider of microbiome-based dermatology therapeutics and consumer products, offering bioengineered live biotherapeutic candidates ATR-12 for Netherton syndrome, ATR-04 for EGFR inhibitor-associated rash, and protein candidate ATR-01 for ichthyosis vulgaris; and a microbiome dermatology platform to develop products for skin disease treatment and skin appearance improvement; plus topical ointments and creams for dryness, redness, flakiness, and inflammation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Azitra company profile →
Tango Therapeutics Logo

Tango Therapeutics

HQ: United States Website
  • Description: Provider of next-generation cancer therapies leveraging synthetic lethality, including TNG908 and TNG462, PRMT5 inhibitors for MTAP-deleted cancers; TNG260, a CoREST inhibitor aimed at reversing immune evasion in STK11-mutant cancers; and TNG348, a USP1 inhibitor for BRCA1/2-mutant and other HRD+ cancers, all in Phase 1/2 trials. Also provides a CRISPR-based functional genomics platform to identify synthetic lethal targets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tango Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Genoway

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Genoway

2.2 - Growth funds investing in similar companies to Genoway

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Genoway

4.2 - Public trading comparable groups for Genoway

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Genoway

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Genoway

What does Genoway do?

Genoway is a provider of genetically modified mouse, rat, and cell line models for preclinical research in biopharma and academia. Delivers humanized, knockin, and conditional knockout models and inducible, spatiotemporal gene control using RMCE, FLEx, SSR, TET system, and homologous recombination, enabling gene insertions, deletions, inversions and to predict the success of new therapies.

Who are Genoway's competitors?

Genoway's competitors and similar companies include Seer, NeoPhore, Medicinal Genomics, Azitra, and Tango Therapeutics.

Where is Genoway headquartered?

Genoway is headquartered in France.

How many employees does Genoway have?

Genoway has 1,000 employees 🔒.

When was Genoway founded?

Genoway was founded in 2010 🔒.

What sector and industry vertical is Genoway in?

Genoway is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Genoway

Who are the top strategic acquirers in Genoway's sector and industry

Top strategic M&A buyers and acquirers in Genoway's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Genoway?

Top strategic M&A buyers groups and sectors for Genoway include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Genoway's sector and industry vertical

Which are the top PE firms investing in Genoway's sector and industry vertical?

Top PE firms investing in Genoway's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Genoway's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Genoway's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Genoway's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Genoway include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Genoway's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Genoway?

The key public trading comparables and valuation benchmarks for Genoway include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Genoway for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Genoway with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Genoway's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Genoway with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Genoway's' sector and industry vertical?

Access recent funding rounds and capital raises in Genoway's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Genoway